Cystic Fibrosis Foundation – Clinical Pilot and Feasibility Award

February 14, 2020 by


The intent of the Clinical Pilot and Feasibility Award is to enable investigators to collect sufficient preliminary data to determine the best strategies and methods for approaching a major question that ultimately will require assessment through a larger scale research and/or multi-center, collaborative clinical trial. Support may be requested for $80,000 annually (plus 12 percent for indirect costs) for up to two years.


Extensive survey input from the CF community (people with CF, family members, and caregivers) helped identified key research Areas of Encouragement that are most important to them. The areas selected by the CF community are listed below in order of prioritization. Applications may address any topic area advancing CF care, treatment, or research. However, applications addressing the following areas are particularly encouraged:

  1. Respiratory microorganism detection and treatment
  2. Gastrointestinal symptoms (including, but not limited to, gastroesophageal reflux disease (GERD), Distal Intestinal Obstruction Syndrome  (DIOS), and pancreatitis)
  3. Reducing treatment burden
  4. CF-related diabetes
  5. Diet and nutrition
  6. Mental health
  7. CF-related liver disease
  8. Exercise
  9. Sinus disease
  10. Allergies and asthma in CF
  11. Alternative/holistic treatments and therapies
  12. Sexual reproductive health
  13. Bone/joint health
  14. Pain management

Key Dates

All letters of intent and full applications must be submitted online at proposalCENTRAL by 5 p.m. ET on the following deadlines.

  • Letter of Intent: September 27, 2019
  • Full application: February 10, 2020

URL for more information

Filed Under: Funding Opportunities